Under construction – not a live service
Sign in
Taking peopleNo phase

Adaptation of Pediatric Speech Audiometry Tests Into Other Languages

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 2 and 7 years old?

Source: NCT07156825, who can take part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Semmelweis University
Trial code
NCT07156825
Record updated
26 January 2026
Original description
The objective of this study was to offer a comprehensive framework for the adaptation of speech audiometric tests into other languages. To date, this is the first universal protocol of its kind that systematically considers linguistic, phonological, and audiological aspects.Read full original descriptionShow less

Methodological Guide for the Adaptation of Pediatric Speech Audiometry Tests Into Other Languages

The objective of this study was to offer a comprehensive framework for the adaptation of speech audiometric tests into other languages. To date, this is the first universal protocol of its kind that systematically considers linguistic, phonological, and audiological aspects.

The present paper provides a protocol and an example for adaptation and standardization of the Mainzer Audiometric Test for Children (MATCH) to another language.

Inclusion: Age: limits for age groups: 2-4,5; 4,5-5,5; 5,5-7, respectively; For control goups: normal hearing verified by pure tone audiometry and tympanometry; For hearing-impairment groups: stable sensorineural hearing loss confirmed by audiological diagnostics.

Exclusion: Children presenting with symptoms of upper respiratory tract infections; Known speech-language developmental disorders; Cognitive disorders.

ClinicalTrials.gov NCT07156825